During the past decade, Gemeinschaftspraxis für Hämatologie und Onkologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gemeinschaftspraxis für Hämatologie und Onkologie" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Gemeinschaftspraxis für Hämatologie und Onkologie" are "Multiple Myeloma" (2 trials), "Gaucher Disease" (1 trials), "Lymphoma, Non-Hodgkin" (1 trials) and "Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Gemeinschaftspraxis für Hämatologie und Onkologie" in a lesser frequency.

Most popular intervention types in "Gemeinschaftspraxis für Hämatologie und Onkologie" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "5FU/LV, Oxaliplatin, Bevacizumab, Irinotecan" (1 trials), "Lenalidomide" (1 trials), "Oxaliplatin, 5FU/LV, Bevacizumab" (1 trials), "Revlimid (lenalidomide)" (1 trials) and "Rituximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gemeinschaftspraxis für Hämatologie und Onkologie" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Gemeinschaftspraxis für Hämatologie und Onkologie". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Gemeinschaftspraxis für Hämatologie und Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gemeinschaftspraxis für Hämatologie und Onkologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".